Published in BMC Genomics on November 05, 2013
Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Br J Cancer (2015) 0.93
Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer. Am J Cancer Res (2015) 0.87
Increased expression of miR-222 is associated with poor prognosis in bladder cancer. World J Surg Oncol (2014) 0.84
Upregulation of miRNA3195 and miRNA374b Mediates the Anti-Angiogenic Properties of Melatonin in Hypoxic PC-3 Prostate Cancer Cells. J Cancer (2015) 0.83
The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer. Int J Clin Exp Pathol (2015) 0.82
MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery. Asian J Androl (2016) 0.81
Genome-wide analysis of miRNA and mRNA transcriptomes during amelogenesis. BMC Genomics (2014) 0.81
MicroRNA-222 Controls Human Pancreatic Cancer Cell Line Capan-2 Proliferation by P57 Targeting. J Cancer (2015) 0.81
Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy. Oncotarget (2017) 0.79
MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity. Oncotarget (2016) 0.78
BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression. Oncol Lett (2016) 0.77
Investigation of the molecular mechanisms underlying metastasis in prostate cancer by gene expression profiling. Exp Ther Med (2016) 0.75
miRNAs associated with prostate cancer risk and progression. BMC Urol (2017) 0.75
Computational Analysis of Specific MicroRNA Biomarkers for Noninvasive Early Cancer Detection. Biomed Res Int (2017) 0.75
Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis. Int J Mol Med (2016) 0.75
MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis. Sci Rep (2017) 0.75
Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma. Oxid Med Cell Longev (2017) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
MicroRNA expression profiling in prostate cancer. Cancer Res (2007) 8.04
Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res (2005) 5.44
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer (2010) 4.53
The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci U S A (2009) 2.72
Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol (2009) 2.67
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res (2009) 2.52
MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther (2008) 2.43
Regulation of MicroRNA Biogenesis: A miRiad of mechanisms. Cell Commun Signal (2009) 2.27
Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res (2010) 2.16
Characterization of KRAS rearrangements in metastatic prostate cancer. Cancer Discov (2011) 2.02
MicroRNAs and cancer--new paradigms in molecular oncology. Curr Opin Cell Biol (2009) 1.96
Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate (2008) 1.86
miRNA control of tumor cell invasion and metastasis. Int J Cancer (2010) 1.79
The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res (2010) 1.75
MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer (2010) 1.70
MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J Biol Chem (2010) 1.66
The complexity of prostate cancer: genomic alterations and heterogeneity. Nat Rev Urol (2012) 1.59
MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene (2012) 1.57
Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res (2009) 1.46
miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res (2012) 1.46
Claudin-14 regulates renal Ca⁺⁺ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J (2012) 1.40
Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Clin Cancer Res (2011) 1.19
miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression. Prostate Cancer Prostatic Dis (2010) 1.18
Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis. Curr Biol (2012) 1.15
Altered profile of seminal plasma microRNAs in the molecular diagnosis of male infertility. Clin Chem (2011) 1.14
miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer. Br J Cancer (2012) 1.14
HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis. Bioessays (2012) 1.09
MicroRNAs as new therapeutic targets and tools in cancer. Expert Opin Ther Targets (2011) 1.07
Identification of a new microRNA expression profile as a potential cancer screening tool. Clin Invest Med (2010) 1.05
miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differ (2012) 1.05
miR-210 as a marker of chronic hypoxia, but not a therapeutic target in prostate cancer. Radiother Oncol (2011) 0.96
MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer. FEBS Lett (2012) 0.95
Diet, microRNAs and prostate cancer. Pharm Res (2010) 0.93
Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population. Med Oncol (2011) 0.92
The activity and expression of microRNAs in prostate cancers. Mol Biosyst (2010) 0.91
miRNAs as biomarkers in prostate cancer. Clin Transl Oncol (2012) 0.90
ERCC1 and topoisomerase I expression in small cell lung cancer: prognostic and predictive implications. Int J Oncol (2012) 0.88
PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer. Am J Cancer Res (2012) 0.88
MicroRNA regulation of nonmuscle myosin light chain kinase expression in human lung endothelium. Am J Respir Cell Mol Biol (2013) 0.88
MicroRNA-130b and microRNA-374b mediate the effect of maternal dietary protein on offspring lipid metabolism in Meishan pigs. Br J Nutr (2012) 0.87
Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer. Int J Oncol (2009) 0.87
The expression of Tousled kinases in CaP cell lines and its relation to radiation response and DSB repair. Prostate (2011) 0.84
Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion. Pathobiology (2011) 0.82
Acute lymphoblastic leukemia-derived dendritic cells express tumor associated antigens: PNPT1, PMPCB, RHAMM, BSG and ERCC1. Neoplasma (2009) 0.78
miRNA-374 regulates dexamethasone-induced differentiation of primary cultures of porcine adipocytes. Horm Metab Res (2013) 0.78
Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study. Biomarkers (2007) 0.78
Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials. Eur Spine J (2013) 2.42
Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy. J Clin Oncol (2007) 1.95
Anterior versus posterior approach for treatment of thoracolumbar burst fractures: a meta-analysis. Eur Spine J (2013) 1.49
GSTT1 null genotype contributes to coronary heart disease risk: a meta-analysis. Mol Biol Rep (2012) 1.39
Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci (2009) 1.33
Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol Sci (2006) 1.24
Conditions of endoplasmic reticulum stress stimulate lipid droplet formation in Saccharomyces cerevisiae. Biochem J (2009) 1.14
Relationship between different skin incisions and the injury of the infrapatellar branch of the saphenous nerve during anterior cruciate ligament reconstruction. Chin Med J (Engl) (2007) 1.12
CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value. Cancer Invest (2009) 1.10
SOXs in human prostate cancer: implication as progression and prognosis factors. BMC Cancer (2012) 1.08
The type II Arabidopsis formin14 interacts with microtubules and microfilaments to regulate cell division. Plant Cell (2010) 1.08
Characterization of arsenate reductase in the extract of roots and fronds of Chinese brake fern, an arsenic hyperaccumulator. Plant Physiol (2005) 1.08
CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncology (2008) 1.06
Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome. Pathol Oncol Res (2011) 1.03
Effects of transforming growth factor-beta1 and vascular endothelial growth factor 165 gene transfer on Achilles tendon healing. Matrix Biol (2009) 1.02
Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology (2009) 1.02
Adenovirus-mediated transfer of siRNA against Runx2/Cbfa1 inhibits the formation of heterotopic ossification in animal model. Biochem Biophys Res Commun (2006) 1.01
MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1. Int J Cancer (2014) 0.96
CD147 expression indicates unfavourable prognosis in prostate cancer. Pathol Oncol Res (2009) 0.96
Protective effects of 7-nitroindazole on ketamine-induced neurotoxicity in rat forebrain culture. Neurotoxicology (2008) 0.96
MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer. FEBS Lett (2012) 0.95
Expression and clinical significance of CD147 in genitourinary carcinomas. J Surg Res (2008) 0.95
Characterization of soil heavy metal contamination and potential health risk in metropolitan region of northern China. Environ Monit Assess (2010) 0.95
Proteome analysis of Saccharomyces cerevisiae under metal stress by two-dimensional differential gel electrophoresis. Electrophoresis (2003) 0.95
A novel polysaccharide from Se-enriched Ganoderma lucidum induces apoptosis of human breast cancer cells. Oncol Rep (2011) 0.95
[Expression and clinical significance of HMGB1 and RAGE in cervical squamous cell carcinoma]. Zhonghua Zhong Liu Za Zhi (2008) 0.92
Induction of apoptosis and G2/M arrest by 2-methoxyestradiol in human cervical cancer HeLaS3 cells. Anticancer Res (2004) 0.92
Association of estrogen receptor alpha polymorphisms with breast cancer risk in older Caucasian women. Int J Cancer (2005) 0.92
Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population. Med Oncol (2011) 0.92
An electrochemical stripping metalloimmunoassay based on silver-enhanced gold nanoparticle label. Biosens Bioelectron (2005) 0.91
Articular cartilage repair using dedifferentiated articular chondrocytes and bone morphogenetic protein 4 in a rabbit model of articular cartilage defects. Arthritis Rheum (2008) 0.91
Spatial distribution of arsenic and temporal variation of its concentration in rice. New Phytol (2010) 0.90
Synergistic inhibition of endochondral bone formation by silencing Hif1α and Runx2 in trauma-induced heterotopic ossification. Mol Ther (2011) 0.90
FIMBRIN1 is involved in lily pollen tube growth by stabilizing the actin fringe. Plant Cell (2012) 0.90
Comparison of osteogenic potentials of BMP4 transduced stem cells from autologous bone marrow and fat tissue in a rabbit model of calvarial defects. Calcif Tissue Int (2009) 0.89
Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett (2002) 0.88
Effects of co-culturing BMSCs and auricular chondrocytes on the elastic modulus and hypertrophy of tissue engineered cartilage. Biomaterials (2012) 0.88
Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis. Med Oncol (2012) 0.88
Fibrin sealant before wound closure in total knee arthroplasty reduced blood loss: a meta-analysis. Knee Surg Sports Traumatol Arthrosc (2014) 0.88
Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer. Med Oncol (2008) 0.88
BMP4 increases canonical transient receptor potential protein expression by activating p38 MAPK and ERK1/2 signaling pathways in pulmonary arterial smooth muscle cells. Am J Respir Cell Mol Biol (2013) 0.87
The roles of TGF-beta1 gene transfer on collagen formation during Achilles tendon healing. Biochem Biophys Res Commun (2009) 0.87
Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy. Clin Invest Med (2011) 0.87
Fluid intake and the risk of bladder cancer: results from the South and East China case-control study on bladder cancer. Int J Cancer (2010) 0.87
Expression of SOCSs in human prostate cancer and their association in prognosis. Mol Cell Biochem (2013) 0.87
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer. Med Oncol (2013) 0.86
Role of aggregated medin in the pathogenesis of thoracic aortic aneurysm and dissection. Lab Invest (2007) 0.86
Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer. Int J Gynecol Cancer (2013) 0.86
Environmental contextualisation of potential toxic elements and polycyclic aromatic hydrocarbons in biochar. Environ Pollut (2012) 0.86
Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues. Am J Surg Pathol (2005) 0.85
Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer. Med Oncol (2013) 0.85
Estrogen metabolizing polymorphisms and breast cancer risk among older white women. Breast Cancer Res Treat (2005) 0.85
Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas. Clin Transl Oncol (2012) 0.85
Safety and efficacy of intra-articular injection of tranexamic acid in total knee arthroplasty. Orthopedics (2014) 0.85
MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer. Pathol Oncol Res (2013) 0.85